AQbD-Assisted Development and Validation of a Stability-Indicating and Greener HPTLC- Densitometric Method for Simultaneous Determination of Dapagliflozin and Sitagliptin in Pharmaceutical Formulations
This study presents a robust, stability-indicating, and greener HPTLC-densitometric method for the simultaneous determination of dapagliflozin and sitagliptin in pharmaceutical formulations, which was systematically optimized using an Analytical Quality by Design (AQbD) approach and fully validated according to ICH guidelines.